Tag Archives: Community Catalyst

Delay of Generics Hurts Consumer,
Taxpayer Wallets, and Patient Health

  To insure patent extensions of high-priced, blockbuster drugs, brand-name drug companies frequently pay generic drug manufacturers to stay out of the market. It makes cheaper, more affordable generic unavailable for years. The strategy is referred to as “Pay for … Continue reading

Posted in Drug costs | Tagged , , , , , , , | Comments Off on Delay of Generics Hurts Consumer,
Taxpayer Wallets, and Patient Health